Novel metrics for quantifying the capacity of subgroup-defining variables to yield efficient treatment rules

by   Mohsen Sadatsafavi, et al.

A major objective of subgroup analysis in clinical trials is to explore to what extent patient characteristics can determine treatment outcomes. Conventional one-variable-at-a-time subgroup analysis based on statistical hypothesis testing of covariate-by-treatment interaction is ill-suited for this purpose. The application of decision theory results in treatment rules that compare the expected benefit of treatment given the patient's covariates against a treatment threshold. However, determining treatment threshold is often context-specific, and any given threshold might seem arbitrary at the reporting stages of a clinical trial. We propose novel, threshold-free metrics that quantify the capacity of a set of covariates towards concentrating treatment benefit. Our proposed framework is based on the concept of Improvement Upon Randomization: the extent to which a covariate-informed treatment rule can reduce the size of the treated population yet generate the same expected outcome as a naïve rule based on random treatment assignment. We use data from a clinical trial of preventive antibiotic therapy for reducing exacerbation rate in Chronic Obstructive Pulmonary Disease to demonstrate the calculations in a step-by-step fashion. The proposed metrics have intuitive and theoretically sound interpretations and enable comparison of arbitrary sets of covariates on scalar, scale-free metrics. They can be estimated with relative ease for a wide class of regression models and can accompany conventional metrics for subgroup analysis when reporting the results of clinical trials. Beyond the conceptual developments presented in this work, various aspects of estimation and inference for such metrics needs to be pursued in future research.


page 1

page 2

page 3

page 4


Flexible Inference of Optimal Individualized Treatment Strategy in Covariate Adjusted Randomization with Multiple Covariates

To maximize clinical benefit, clinicians routinely tailor treatment to t...

Methodological concerns about 'concordance-statistic for benefit' as a measure of discrimination in treatment benefit prediction

Prediction algorithms that quantify the expected benefit of a given trea...

Survival Analysis Using a 5-Step Stratified Testing and Amalgamation Routine in Randomized Clinical Trials

Randomized clinical trials are often designed to assess whether a test t...

Leveraging Historical Data for High-Dimensional Regression Adjustment, a Composite Covariate Approach

The amount of data collected from patients involved in clinical trials i...

Efficient nonparametric estimation of the covariate-adjusted threshold-response function, a support-restricted stochastic intervention

Identifying a biomarker or treatment-dose threshold that marks a specifi...

A Sequential Significance Test for Treatment by Covariate Interactions

Due to patient heterogeneity in response to various aspects of any treat...

Please sign up or login with your details

Forgot password? Click here to reset